[Editorial] Forging ahead on fibromyalgia

Fibromyalgia is one of the most challenging chronic pain conditions to treat. Historically stigmatised and its existence still doubted by some physicians, patients often experience substantial diagnostic delays. Insufficient understanding of disease mechanisms and patient heterogeneity means that no drug treatment provides substantial benefit in fibromyalgia, prompting the search for new interventions. Research into disease mechanisms forges onwards, with new discoveries providing hope for improved patient outcomes.